News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
378,487 Results
Type
Article (25824)
Company Profile (61)
Press Release (352602)
Section
Business (104249)
Career Advice (448)
Deals (16873)
Drug Delivery (50)
Drug Development (47552)
Employer Resources (47)
FDA (12249)
Job Trends (8434)
News (185862)
Policy (19404)
Tag
Academia (1736)
Alliances (26682)
Alzheimer's disease (770)
Approvals (12276)
Artificial intelligence (133)
Bankruptcy (140)
Best Places to Work (6899)
Breast cancer (150)
Cancer (1098)
Cardiovascular disease (89)
Career advice (407)
Cell therapy (172)
Clinical research (40020)
Collaboration (357)
Compensation (90)
COVID-19 (1474)
C-suite (95)
Data (1113)
Diabetes (135)
Diagnostics (3462)
Earnings (36342)
Events (51134)
Executive appointments (356)
FDA (12966)
Funding (322)
Gene therapy (103)
GLP-1 (355)
Government (3007)
Healthcare (12173)
Infectious disease (1532)
Inflammatory bowel disease (72)
IPO (7030)
Job creations (1837)
Job search strategy (377)
Layoffs (159)
Legal (3623)
Lung cancer (188)
Lymphoma (72)
Manufacturing (82)
Medical device (12791)
Medtech (12794)
Mergers & acquisitions (10068)
Metabolic disorders (338)
Neuroscience (1015)
NextGen: Class of 2025 (3931)
Non-profit (2820)
Northern California (1073)
Obesity (183)
Opinion (65)
Parkinson's disease (72)
Patents (78)
People (34438)
Phase I (11470)
Phase II (17340)
Phase III (14217)
Pipeline (395)
Postmarket research (1668)
Preclinical (3551)
Radiopharmaceuticals (158)
Rare diseases (155)
Real estate (2840)
Regulatory (13968)
Research institute (1600)
Southern California (927)
Startups (2118)
United States (10296)
Vaccines (314)
Weight loss (124)
Date
Today (6)
Last 7 days (323)
Last 30 days (1379)
Last 365 days (19435)
2025 (2466)
2024 (19863)
2023 (22753)
2022 (30701)
2021 (32998)
2020 (32197)
2019 (28428)
2018 (21819)
2017 (18920)
2016 (18123)
2015 (21207)
2014 (16034)
2013 (13246)
2012 (14363)
2011 (14627)
2010 (13185)
Location
Africa (353)
Arizona (104)
Asia (24327)
Australia (3849)
California (2403)
Canada (1035)
China (272)
Colorado (138)
Connecticut (145)
Delaware (84)
Europe (47442)
Florida (423)
Georgia (104)
Illinois (310)
Indiana (184)
Japan (86)
Kansas (68)
Maryland (538)
Massachusetts (1703)
Michigan (95)
Minnesota (232)
New Jersey (869)
New York (755)
North Carolina (480)
Northern California (1073)
Ohio (111)
Pennsylvania (671)
South America (520)
Southern California (927)
Texas (424)
Utah (90)
Washington State (189)
378,487 Results for "actuated medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Actuate Therapeutics to Participate in Upcoming Investor Conferences in February
February 6, 2025
·
4 min read
Press Releases
Actuate Therapeutics to be Added to Russell 2000® Index
November 27, 2024
·
4 min read
Deals
Actuate Therapeutics Files Registration Statement for Initial Public Offering
Actuate Therapeutics, Inc. announced that it has filed a registration statement with the Securities and Exchange Commission for a proposed initial public offering of its common stock.
May 28, 2024
·
2 min read
Press Releases
Actuate Therapeutics Receives EMA Orphan Medicinal Product Designation for Elraglusib for the Treatment of Pancreatic Cancer
January 7, 2025
·
6 min read
Press Releases
Actuate Therapeutics Announces Positive Interim Phase 2 Data of Elraglusib in First Line Treatment of Metastatic Pancreatic Cancer
December 17, 2024
·
8 min read
BioMidwest
Actuate Therapeutics Announces Poster Presentations at the 2024 AACR Annual Meeting
Actuate Therapeutics, Inc. announced today two poster presentations from scientific collaborators at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 5-10, 2024, in San Diego, California.
April 8, 2024
·
1 min read
Press Releases
Actuate Therapeutics Announces Closing of Initial Public Offering
August 15, 2024
·
4 min read
Business
Actuate Therapeutics Announces Pricing of Initial Public Offering
August 12, 2024
·
4 min read
Press Releases
Actuate Receives FDA Orphan Drug Designation for Elraglusib for Treatment of Soft Tissue Sarcomas
September 11, 2024
·
6 min read
Press Releases
Actuate to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 5, 2024
·
1 min read
1 of 37,849
Next
